Speeding up early drug development

Drug aliquots for R&D

Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.

Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products

aliquoted from medicines

Drug Aliquots

In Stock

Download | In-stock aliquots

Drug Aliquots

On Demand

Download | On-demand aliquots

Your Desired

Molecule

best selling products

molecular classes

NEW BATCHES

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Quantity per vial	Expiry Date	Price
Adalimumab 1120078A	TNF alpha	Biosimilar , Monoclonal Antibody	Amgevita®	2 mg	2021.12	304,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 1251992	TNF alpha	Monoclonal Antibody	Humira®	4 mg	2026.02	451,00 €	Max: 3 Min: 1 Step: 1
Adalimumab 1825216	TNF alpha	Biosimilar , Monoclonal Antibody	Hulio®	2 mg	2023.02	304,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 1909689A	TNF alpha	Biosimilar , Monoclonal Antibody	Hukyndra®	2 mg	2023.10	354,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 2LJP01T11	TNF alpha	Biosimilar , Monoclonal Antibody	Yuflyma®	4 mg	2024.02	354,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 73254XH03	TNF alpha	Monoclonal Antibody	Humira®	4 mg	2018.12	451,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 76287XH07	TNF alpha	Monoclonal Antibody	Humira®	4 mg	2019.03	451,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 76287XH11	TNF alpha	Monoclonal Antibody	Humira®	4 mg	2019.03	451,00 €	Max: 3 Min: 1 Step: 1
Adalimumab 80315XH04	TNF alpha	Monoclonal Antibody	Humira®	4 mg	2019.07	451,00 €	Max: 8 Min: 1 Step: 1
Adalimumab AU034994	TNF alpha	Biosimilar , Monoclonal Antibody	Idacio®	2 mg	2023.10	355,00 €	Max: 10 Min: 1 Step: 1

1 2

Evidentic – fast, accurate, secure

Our products are empowering researchers worldwide

"Overall, I'm very happy with my purchase from Evidentic, and I would highly recommend them to anyone looking for high-quality products with sustainable packaging."

Tara Foley

Senior Technical Officer | Dept of Anatomy and Neuroscience

"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries."

Dr. Cassey McRae

Senior R&D Scientist at Avacta Life Sciences

"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."

Prof. Dr. Henning von Horsten

Life Science Engineering, HTW Berlin

“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”

Ivanna Hrynchak

PhD Student ICNAS, Universidade de Coimbra

“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”

Tom H. Jin, M.D.

Director of Process Development

"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”

Thibault Jonckheere

CEO

"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"

Prof. (emeritus) Dr. Florian Wurm 

CSO & Founder

”Evidentic can supply different batches of reference products for pre-clinical research. The quick access allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”

Anjan Selz

Vice President
Head of Biosimilars EMEA

Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.

Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.

Speeding up early drug development

Drug aliquots for R&D

Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.

Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products

aliquoted from medicines

Drug Aliquots

Drug Aliquots

Your Desired

best selling products

molecular classes

NEW BATCHES

Bevacizumab

Vedolizumab

Enfortumab Vedotin

Thyrotropin alfa

Agalsidase beta

Loncastuximab tesirine

Amivantamab

Teclistamab

Rituximab

Brentuximab vedotin

Evidentic – fast, accurate, secure

Our products are empowering researchers worldwide​

Tara Foley

Senior Technical Officer | Dept of Anatomy and Neuroscience

Dr. Cassey McRae

Senior R&D Scientist at Avacta Life Sciences

Prof. Dr. Henning von Horsten

Life Science Engineering, HTW Berlin

Ivanna Hrynchak

PhD Student ICNAS, Universidade de Coimbra

Tom H. Jin, M.D.

Director of Process Development

Thibault Jonckheere

CEO

Prof. (emeritus) Dr. Florian Wurm

CSO & Founder

Anjan Selz

Vice President Head of Biosimilars EMEA

Recent Articles

Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.

Our products are empowering researchers worldwide

Prof. (emeritus) Dr. Florian Wurm 

Vice President
Head of Biosimilars EMEA